Rana Mahmood

Colchester Hospital

Papers

1

Total Citations

31

H-Index

1

About

Rana Mahmood is a leading clinical researcher in radiation oncology, with a primary focus on prostate cancer treatment and comparative effectiveness research. Her most impactful work centers on the PACE-A trial, an international phase 3 randomised controlled trial that directly compares stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer. This landmark study, cited 31 times, addresses a critical gap in evidence by providing randomised data on quality-of-life outcomes between these two major treatment modalities. Mahmood’s contributions have helped clarify therapeutic equipoise in early-stage prostate cancer management, offering patients and clinicians robust evidence for shared decision-making. Her research demonstrates a commitment to patient-centered outcomes, particularly in preserving quality of life after treatment. With her work influencing clinical guidelines and practice patterns, Mahmood stands at the forefront of integrating advanced radiotherapy techniques into standard care. Her ongoing investigations continue to shape the landscape of prostate cancer treatment, making her a key voice in the ongoing debate between surgical and radiotherapeutic approaches.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.
31 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Colchester Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago